Mondaq Asia Pacific: Food, Drugs, Healthcare, Life Sciences
Norton Rose Fulbright Australia
Only 25% of respondents believe greater food safety regulation is necessary, despite concern in some emerging markets.
Norton Rose Fulbright Australia
The Food Safety Modernization Act (FSMA) is the US Food and Drug Administration's most sweeping reform in over 70 years.
DaHui Lawyers
A number of recent commercial bribery cases concerning multinational pharmaceutical companies have drawn extensive attention.
Eiger
This article outlines the implications of the new Free Trade Agreement between China and Switzerland in relation to the trade in medical devices.
King & Wood Mallesons
The China FDA has recently promulgated the Provisions on the Food and Drug Administrative Penalty Procedure.
King & Wood Mallesons
The Revised Regulations will come into effective on 1 June 2014, presenting some major changes.
Benesch Law
On December 26, 2013, the Commission promulgated Nine Prohibitions to Strengthen Ethical Conduct in the Healthcare Industry Circular [2013] No. 49.
MWE China Law Offices
The State Council of the Chinese Central Government unveiled a revised Regulation on the Supervision and Administration of Medical Devices.
Sheppard Mullin Richter & Hampton
The Regulations on Supervision and Administration of Medical Devices was amended and promulgated by the State Council, effective June 1st, 2014.
Sheppard Mullin Richter & Hampton
On December 25, 2013, the National Health and Family Planning Commission of China issued the amended "Provisions Regarding the Establishment of Commercial Bribery Blacklist in the Pharmaceutical Purchase and Sales Industries", which came into effect on March 1, 2014.
King & Wood Mallesons
The NHFPC has strengthened the healthcare industry to crack down on commercial bribery and illegal medical practices.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
On March 1, 2014, Circular No. 50 went into effect, promulgated to regulate the conduct of pharmaceutical and medical device companies that do business in China.
Ropes & Gray LLP
On February 7, 2014, the China Food and Drug Administration promulgated a notice titled "The Fast Track Approval Process for Innovative Medical Device (Tentative)", effective as of March 1, 2014.
King & Wood Mallesons
The new interpretation focuses on issues such as intentionally purchasing counterfeit products and online shopping.
McDermott Will & Emery
It has been several months since publicity began about aggressive investigations of potential bribery in the pharmaceutical industry in China.
King & Wood Mallesons
Some brands are not found in China because some cosmetics and body care companies are against animal testing.
King & Wood Mallesons
The new Provisions will strengthen the Chinese pharmaceutical industry, to regulate to fight against commercial bribery.
Mayer Brown JSM
The Pharmacy and Poisons (Amendment) Bill 2014 ("Bill") was introduced in March 2014. The Bill proposes substantial changes aimed at improving and updating the regulatory framework of the Pharmacy and Poisons Ordinance.
PSA Legal Counsellors
The National Pharmaceutical Pricing Authority issued guidelines for stoppage of scheduled formulations under paragraph 21(2) of Drug Pricing Control Order, 2013.
PSA Legal Counsellors
The Health Ministry initiated consultation on government action plan for the first 100 days with respect to healthcare reforms.
Most Popular Recent Articles
Vaish Associates Advocates
One of the potential threats for manufacturing and sale of food/health supplements such as "Dietary food supplement", "Food supplements", "Nutritional supplements", "Health supplements", is its categorization in the category of "Food" or "Drugs", as there is a very thin line between "drugs/ medicines" and "nutritional supplements".
Vaish Associates Advocates
The food processing industry one of the largest industries in India is widely recognized as a 'sunrise industry' in India having huge potential for uplifting the agricultural economy, creation of large scale processed food manufacturing and food chain facilities, and the resultant generation of employment and export earnings.
Singh & Associates
Clinical research is the key to the discovery of latest diagnostic methods and to develop modern drugs for treatment of diseases.
Singh & Associates
With the objective to improvise and endow with the basic health care and availability of basic medicines at an affordable price across the country, the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, , notified the Drug (Prices Control) Order 2013("DPCO 2013") in May 2013, which may fluctuate the pricing of 348 essential medicines.
Singh & Associates
In the last few years, the Indian pharmaceutical sector has seen an immense growth both in terms of domestic and international stratum.
Vaish Associates Advocates
"Clinical Trials" and debates associated with it have been in headlines since past few months pursuant to the strict view taken by the apex court on the matter.
DaHui Lawyers
A number of recent commercial bribery cases concerning multinational pharmaceutical companies have drawn extensive attention.
Singh & Associates
A discussion on the aim of the National Food Security Bill.
Duane Morris LLP
In addition to mobile health opportunities in the United States, tremendous potential for growth exists throughout the world, including in Southeast Asia.
Singh & Associates
The Indian pharmaceutical industry is emerging as one of the most prospective markets in the global strata in terms of its potential.
Article Search Using Filters
Related Topics
Popular Authors
Popular Contributors
Tools
Font Size:
Translation
Channels
Mondaq on Twitter